In the remaining IDO-negative cases, in vitro challenge with IFN-γ up-regulated IDO mRNA, but not IDO protein, suggesting that post-translational stimuli may be required for the acquisition of IDO competency by AML cells [31]. The gene discussed is IFNG; the disease is acute myeloid leukemia.